Therapeutic management options for stage III non-small cell lung cancer

Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered locally advanced at the time of diagnosis. Patients with locally advanced stage III NSCLC consists of a heterogeneous popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Stephanie M, Shaikh, Talha, Hallman, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309711/
https://www.ncbi.nlm.nih.gov/pubmed/28246582
http://dx.doi.org/10.5306/wjco.v8.i1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309711/
https://www.ncbi.nlm.nih.gov/pubmed/28246582
http://dx.doi.org/10.5306/wjco.v8.i1.1

Ejemplares similares